by wukong-admin856 | Jun 30, 2026 | Market Intelligence
A signed contract in Türkiye is rarely the finish line that foreign companies assume it to be. More often, it marks the point where the real relationship starts, and where the assumptions a European team brought into the room start getting tested. This guide breaks...
by wukong-admin856 | Jun 26, 2026 | Expansion Playbooks
Türkiye does not punish companies for arriving unprepared. It simply lets them find out the hard way, twelve months and one failed distributor agreement later. This guide sets out what actually has to happen, in the right order, for a European company to...
by wukong-admin856 | Jun 22, 2026 | Market Intelligence
Türkiye is the 19th largest pharmaceutical market in the world. As of January 2025, only 3% of medicines approved by the European Medicines Agency between 2020 and 2023 were available to Turkish patients. Germany: 90%. EU average: 46%. These two facts belong to the...
by wukong-admin856 | May 26, 2026 | Uncategorized
Medical device registration in Türkiye is often described as “EU-aligned, so straightforward for European manufacturers.” The alignment is real. The straightforward part is not. EU MDR compliance is the entry prerequisite, not the process itself. On top of...
by wukong-admin856 | May 19, 2026 | Uncategorized
Turkey is a USD 3.3 to 4.5 billion medical device market with structural import dependence above 75%, a hospital network of 1,566 facilities, near-universal insurance coverage, and regulatory alignment with the EU. On paper, it looks like one of the more accessible...
